GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LAVA Therapeutics NV (FRA:4PKB) » Definitions » Dividend-Payout-to-FFO

LAVA Therapeutics NV (FRA:4PKB) Dividend-Payout-to-FFO


View and export this data going back to 2021. Start your Free Trial

What is LAVA Therapeutics NV Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


LAVA Therapeutics NV Business Description

Traded in Other Exchanges
Address
Yalelaan 62, Utrecht, UT, NLD, 3584 CM
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.